Akebia Therapeutics (AKBA:NAS) Fundamental Valuation Report
Fundamental Valuation Report Akebia Therapeutics(AKBA:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$3.12 (USD) 04/14/2021 Weighted Valuation$3.53 (USD) Overall RatingUndervalued by 13.4% Valuation Models Adjusted Book Value: $3.53 (USD) …
Akebia Therapeutics (AKBA:NAS) Fundamental Valuation Report Read more »
Read More